205 related articles for article (PubMed ID: 9844830)
1. Primary biliary cirrhosis. Is (and how much of) the pathology preventible?
Bar-Dayan Y; Gershwin ME; Levi Y; Amital H; Shoenfeld Y
Immunol Res; 1998; 18(2):117-23. PubMed ID: 9844830
[TBL] [Abstract][Full Text] [Related]
2. The challenges of primary biliary cholangitis: What is new and what needs to be done.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D; Vierling JM; Adams D; Alpini G; Banales JM; Beuers U; Björnsson E; Bowlus C; Carbone M; Chazouillères O; Dalekos G; De Gottardi A; Harada K; Hirschfield G; Invernizzi P; Jones D; Krawitt E; Lanzavecchia A; Lian ZX; Ma X; Manns M; Mavilio D; Quigley EM; Sallusto F; Shimoda S; Strazzabosco M; Swain M; Tanaka A; Trauner M; Tsuneyama K; Zigmond E; Gershwin ME
J Autoimmun; 2019 Dec; 105():102328. PubMed ID: 31548157
[TBL] [Abstract][Full Text] [Related]
3. Primary biliary cirrhosis in adults.
Momah N; Lindor KD
Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):427-33. PubMed ID: 24580040
[TBL] [Abstract][Full Text] [Related]
4. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
5. Primary biliary cirrhosis.
Kumagi T; Heathcote EJ
Orphanet J Rare Dis; 2008 Jan; 3():1. PubMed ID: 18215315
[TBL] [Abstract][Full Text] [Related]
6. The diagnosis and treatment of primary biliary cirrhosis.
Kim KA; Jeong SH
Korean J Hepatol; 2011 Sep; 17(3):173-9. PubMed ID: 22102382
[TBL] [Abstract][Full Text] [Related]
7. Primary biliary cirrhosis in the era of liver transplantation.
Raczyńska J; Habior A; Pączek L; Foroncewicz B; Pawełas A; Mucha K
Ann Transplant; 2014 Sep; 19():488-93. PubMed ID: 25262831
[TBL] [Abstract][Full Text] [Related]
8. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
[TBL] [Abstract][Full Text] [Related]
9. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
[TBL] [Abstract][Full Text] [Related]
10. Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients.
Mijic M; Saric I; Delija B; Lalovac M; Sobocan N; Radetic E; Martincevic D; Filipec Kanizaj T
Can J Gastroenterol Hepatol; 2022; 2022():7831165. PubMed ID: 35910038
[TBL] [Abstract][Full Text] [Related]
11. [Primary biliary cirrhosis].
Chon CY; Park JY
Korean J Hepatol; 2006 Sep; 12(3):364-72. PubMed ID: 16998288
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
13. Primary biliary cirrhosis.
Rinella ME
Ann Hepatol; 2006; 5(3):198-200. PubMed ID: 17060882
[TBL] [Abstract][Full Text] [Related]
14. [Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis].
Yuan Z; Jia G; Han Y
Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):73-76. PubMed ID: 30685931
[TBL] [Abstract][Full Text] [Related]
15. Primary biliary cirrhosis.
Kaplan MM; Gershwin ME
N Engl J Med; 2005 Sep; 353(12):1261-73. PubMed ID: 16177252
[No Abstract] [Full Text] [Related]
16. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of primary biliary cirrhosis.
Ali AH; Carey EJ; Lindor KD
Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237
[TBL] [Abstract][Full Text] [Related]
18. Decreased infiltration of CD4
Yu K; Li P; Xu T; Xu J; Wang K; Chai J; Zhao D; Liu Y; Wang Y; Ma J; Fan L; Guo S; Li Z; Li M; Wang Z
Pathol Res Pract; 2021 Jan; 217():153291. PubMed ID: 33249399
[TBL] [Abstract][Full Text] [Related]
19. Chronic cholestatic diseases.
Poupon R; Chazouillères O; Poupon RE
J Hepatol; 2000; 32(1 Suppl):129-40. PubMed ID: 10728800
[TBL] [Abstract][Full Text] [Related]
20. Bile acid therapy and markers of immune-mediated damage in primary biliary cirrhosis.
de Caestecker JS
Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):145-7. PubMed ID: 9058624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
